carvacrol has been researched along with Acute Confusional Senile Dementia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celik Topkara, K; Cetinkaya, A; Demir, S; Kilinc, E; Saylan, A | 1 |
| Ashraf, GM; Javed, H; Jha, NK; Mohamed Fizur, NM; Ojha, S | 1 |
| Bazmandegan, G; Hassanshahi, A; Kamiab, Z; Kujawska, M; Nikbakhtzadeh, M; Ramezanpour, S; Zamanian, MY | 1 |
| Abdelgawad, ME; El-Mezayen, HA; El-Naggar, ME; Farrag, AR; Hussein, J; Kamal, MH; Medhat, D | 1 |
| Dogra, AK; Kaufmann, D; Wink, M | 1 |
| Jukic, M; Maksimovic, M; Milos, M; Politeo, O | 1 |
2 review(s) available for carvacrol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
Topics: Alzheimer Disease; Antioxidants; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease | 2023 |
Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cymenes; Disease Models, Animal; Humans; Nervous System Diseases; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Phenols; Protein Serine-Threonine Kinases; Stroke; TRPM Cation Channels | 2021 |
4 other study(ies) available for carvacrol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Therapeutic effects of carvacrol on beta-amyloid-induced impairments in in vitro and in vivo models of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Galantamine; Hippocampus; Humans; Memory Disorders; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Rats; Superoxide Dismutase; Thymol | 2022 |
Evaluation of urinary 8-hydroxy-2-deoxyguanosine level in experimental Alzheimer's disease: Impact of carvacrol nanoparticles.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Advanced Oxidation Protein Products; Alzheimer Disease; Animals; Antioxidants; Brain; Cholinesterases; Cymenes; Disease Models, Animal; Glutathione; Male; Nanoparticles; Neuroprotective Agents; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2019 |
Myrtenal inhibits acetylcholinesterase, a known Alzheimer target.
Topics: Acetylcholinesterase; Alzheimer Disease; Bicyclic Monoterpenes; Cholinesterase Inhibitors; Colorimetry; Cyclohexanols; Cymenes; Enzyme Inhibitors; Eucalyptol; Humans; Monoterpenes; Oils, Volatile; Phytotherapy; Plant Extracts; Terpenes | 2011 |
In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone.
Topics: Acetylcholinesterase; Alzheimer Disease; Benzoquinones; Cymenes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Monoterpenes; Phytotherapy; Plant Oils; Thymol; Thymus Plant | 2007 |